The store will not work correctly when cookies are disabled.
(2R,3'R,6'S)-2',2',6'-trimethyl-3H-spiro[1-benzofuran-2,1'-cyclohexane]-3',5-diol
ID: ALA216298
PubChem CID: 16046115
Max Phase: Preclinical
Molecular Formula: C16H22O3
Molecular Weight: 262.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C[C@H]1CC[C@@H](O)C(C)(C)[C@@]12Cc1cc(O)ccc1O2
Standard InChI: InChI=1S/C16H22O3/c1-10-4-7-14(18)15(2,3)16(10)9-11-8-12(17)5-6-13(11)19-16/h5-6,8,10,14,17-18H,4,7,9H2,1-3H3/t10-,14+,16+/m0/s1
Standard InChI Key: LCCNGMPSHBOPBJ-DRZCJDIDSA-N
Molfile:
RDKit 2D
19 21 0 0 1 0 0 0 0 0999 V2000
-1.5171 -7.3159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5171 -8.1397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8060 -8.5453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0949 -8.1397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0949 -7.3159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8060 -6.8977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0202 -4.9106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3960 -4.1946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2240 -4.2024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6319 -4.9163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3892 -5.6277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2202 -5.6268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4758 -6.4127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1354 -6.4142 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.6217 -6.9071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9335 -6.5972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2111 -7.7590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6402 -3.4901 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.2300 -8.5549 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
11 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 12 1 0
11 12 2 0
12 13 1 0
6 13 1 1
6 14 1 6
14 11 1 0
5 15 1 1
1 16 1 0
9 18 1 0
1 17 1 0
2 19 1 1
M END
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 262.35 | Molecular Weight (Monoisotopic): 262.1569 | AlogP: 2.88 | #Rotatable Bonds: ┄ |
Polar Surface Area: 49.69 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.96 | CX Basic pKa: ┄ | CX LogP: 3.15 | CX LogD: 3.15 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.76 | Np Likeness Score: 2.66 |
References
1. Useglio M, Castellano PM, Operto MA, Torres R, Kaufman TS.. (2006) Synthesis of 3H-spiro[benzofuran-2,1'-cyclohexane] derivatives from naturally occurring filifolinol and their classical complement pathway inhibitory activity., 16 (19): [PMID:16875818] [10.1016/j.bmcl.2006.07.029] |